Document Detail


Relation of Systemic Autoantibodies to the Number of Extraglandular Manifestations in Primary Sjögren's Syndrome: A Retrospective Analysis of 65 Patients in the Netherlands.
MedLine Citation:
PMID:  20864144     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: Extraglandular manifestations (EGM) are often seen in patients with primary Sjögren's syndrome and are probably due to a (more) disturbed immune system. Their relation to systemic autoantibodies remains controversial. We hypothesized that positive serology as reflected by the presence of 1 of more systemic autoantibodies is related to the number of EGM.
METHODS: To this purpose, all patients, visiting a large nonacademic teaching hospital, with primary Sjögren's syndrome, according to the revised American-European classification criteria of 2002, were retrospectively analyzed.
RESULTS: In this group of 65 patients, systemic autoantibodies were abundant: anti-Sjögren syndrome A antigen (SSA) and/or anti-Sjögren syndrome B antigen (SSB) (80%), immunoglobulinM-Rheumatoid factor (IgM-RF) (68%), and anti-nuclear antibodies (ANA) (77%). Their presence was often found together and correlated to the presence of hypergammaglobulinemia. There was a statistically significant correlation between the number of systemic autoantibodies and the total number of EGM (P = 0.025). Anti-SSA was the strongest predictor of the presence of EGM (OR = 4.67, P = 0.024).
CONCLUSIONS: These findings indicate that a more disturbed immune system, as reflected by B-cell hyperactivity, with autoantibody formation and hypergammaglobulinemia, is associated with more systemic manifestations in patients with primary Sjögren's syndrome.
Authors:
Evert-Jan Ter Borg; Anna P Risselada; Johannes C Kelder
Related Documents :
11458244 - Syndromes with salivary dysfunction predispose to tooth wear: case reports of congenita...
15017814 - Primary sjögren's syndrome.
9715014 - Using ultrasonography to diagnose sjögren's syndrome.
9188924 - Anti-inflammatory drugs do not alleviate bronchial hyperreactivity in sjögren's syndrome.
23294384 - Substance use, gender, socioeconomic status and metabolic syndrome among adults in taiwan.
10759344 - Treatment of charles bonnet syndrome with valproate.
Publication Detail:
Type:  Journal Article     Date:  2010-09-22
Journal Detail:
Title:  Seminars in arthritis and rheumatism     Volume:  40     ISSN:  1532-866X     ISO Abbreviation:  Semin. Arthritis Rheum.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1306053     Medline TA:  Semin Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  547-51     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Department of Rheumatology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Metabolites from fungal laccase-catalysed transformation of sulfonamides.
Next Document:  Hand radiological damage in systemic sclerosis: comparison with a control group and clinical and fun...